BridgeMD
New treatment option for Fibromyalgia
Official title Effect of Physical Exercise and Neuromodulation on Pain, Sleep and Fatigue in Patients With Fibromyalgia
ClinicalTrials.gov ID: NCT07242573
What this study is testing
- What it's testing
- Fibromyalgia (FMS) is a chronic, multifactorial syndrome characterized by widespread pain, fatigue, and cognitive disturbances. This interventional study evaluates the impact of structured physical training using diagnostic-training devices (Zebris treadmill and Alfa balance platform) and transcutaneous neuromodulation (NESA X-Signal) on pain, sleep quality, and overall health status in patients with fibromyalgia and chronic fatigue symptom.
- Time commitment: about 6 weeks
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 20 to 80
You may be able to join if
- Age between 20 and 80 years
- Confirmed diagnosis of fibromyalgia
- Presence of chronic fatigue symptoms
- Stable health condition
- Presence of sleep disturbances
You likely can't join if
- Lack of informed consent or cooperation
- Refusal to undergo procedures beyond standard NFZ physiotherapy
- Cancer
- Neurological disorders (e.g., neuralgia, multiple sclerosis, diabetic polyneuropathy, stroke)
- Diagnosed dementia or cognitive impairment
- Implanted electronic devices (e.g., pacemaker)
See the full eligibility criteria
- Age between 20 and 80 years
- Confirmed diagnosis of fibromyalgia
- Presence of chronic fatigue symptoms
- Stable health condition
- Presence of sleep disturbances
- Ability to provide written informed consent and cooperate during the study
- Lack of informed consent or cooperation
- Refusal to undergo procedures beyond standard NFZ physiotherapy
- Cancer
- Neurological disorders (e.g., neuralgia, multiple sclerosis, diabetic polyneuropathy, stroke)
- Diagnosed dementia or cognitive impairment
- Implanted electronic devices (e.g., pacemaker)
- Internal bleeding or acute febrile illness
- Acute thrombophlebitis
- Hysteria or electric phobia
- Neurotic addiction to stimulation
- Infectious skin diseases (e.g., mycosis, purulent dermatitis)
- Inability to communicate in Polish sufficiently to complete questionnaires or follow instructions
The study team makes the final eligibility decision.
Where it's taking place
- Warsaw, Masovian Voivodeship, Poland
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 6 weeks per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 20 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Warsaw, Masovian Voivodeship, Poland. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.